OZAVANA Trademark

Trademark Overview

On Thursday, March 31, 2016, a trademark application was filed for OZAVANA with the United States Patent and Trademark Office. The USPTO has given the OZAVANA trademark a serial number of 86959644. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 8, 2023. This trademark is owned by Celgene Corporation. The OZAVANA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
ozavana

General Information

Serial Number86959644
Word MarkOZAVANA
Filing DateThursday, March 31, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 8, 2023
Registration Number5149452
Registration DateTuesday, February 28, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 13, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Translation of Words in MarkThe wording "OZAVANA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, September 8, 2023CANCELLED SEC. 8 (6-YR)
Friday, December 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 9, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, December 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, December 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 28, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 28, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 8, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 8, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 3, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 11, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 11, 2016NON-FINAL ACTION E-MAILED
Thursday, August 11, 2016NON-FINAL ACTION WRITTEN
Thursday, August 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 12, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 12, 2016NON-FINAL ACTION E-MAILED
Thursday, May 12, 2016NON-FINAL ACTION WRITTEN
Wednesday, May 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 11, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 6, 2016ASSIGNED TO LIE
Friday, April 22, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 22, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 22, 2016NON-FINAL ACTION E-MAILED
Friday, April 22, 2016NON-FINAL ACTION WRITTEN
Thursday, April 21, 2016ASSIGNED TO EXAMINER
Tuesday, April 5, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 4, 2016NEW APPLICATION ENTERED

Related Keywords

ozavana pharmaceutical disease preparations namely diseases skin cytokine musculoskeletal inhibitory immune